Evidence map›Paper›PMID 42726481›Full record

ArticleJAMA network open2026

Accuracy and Equity of the End-of-Life Care Index in Predicting 1-Year Mortality.

Rachel Kohn, Katherine R Courtright, Maria Grau-Sepulveda, Maren K Olsen, Vanessa L Madden, Bethany Sewell, Dorothy Sheu, Yazmeen S Ahmad, Catherine L Auriemma, Abigail Nimetz and 14 more

Abstract read
In one paragraph

Article in JAMA network open, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

24 authors.

Rachel KohnDepartment of Medicine, Perelman School of Medicine at the University of Pennsylvania, Philadelphia.
Katherine R CourtrightDepartment of Medicine, Perelman School of Medicine at the University of Pennsylvania, Philadelphia.
Maria Grau-SepulvedaDuke Clinical Research Institute, Duke University School of Medicine, Durham, North Carolina.
Maren K OlsenDuke Clinical Research Institute, Duke University School of Medicine, Durham, North Carolina.
Vanessa L MaddenPalliative and Advanced Illness Research Center, Perelman School of Medicine at the University of Pennsylvania, Philadelphia.
Bethany SewellPalliative and Advanced Illness Research Center, Perelman School of Medicine at the University of Pennsylvania, Philadelphia.
Dorothy SheuPalliative and Advanced Illness Research Center, Perelman School of Medicine at the University of Pennsylvania, Philadelphia.
Yazmeen S AhmadPalliative and Advanced Illness Research Center, Perelman School of Medicine at the University of Pennsylvania, Philadelphia.
Catherine L AuriemmaDepartment of Medicine, Perelman School of Medicine at the University of Pennsylvania, Philadelphia.
Abigail NimetzPalliative and Advanced Illness Research Center, Perelman School of Medicine at the University of Pennsylvania, Philadelphia.
Anne DennosDuke Clinical Research Institute, Duke University School of Medicine, Durham, North Carolina.
Kimberly W HartDuke Clinical Research Institute, Duke University School of Medicine, Durham, North Carolina.
Beth CreekmurDepartment of Research and Evaluation, Kaiser Permanente Southern California, Pasadena.
Janet LeeDepartment of Research and Evaluation, Kaiser Permanente Southern California, Pasadena.
Claudia L NauDepartment of Research and Evaluation, Kaiser Permanente Southern California, Pasadena.
Huong Q NguyenDepartment of Research and Evaluation, Kaiser Permanente Southern California, Pasadena.
Susan WangKaiser Permanente Bernard J. Tyson School of Medicine, Pasadena, California.
Grant BoyerTrinity Health, Livonia, Michigan.
Tammy LundstromTrinity Health, Livonia, Michigan.
Lindsey PostemaTrinity Health, Livonia, Michigan.
Daniel J RothTrinity Health, Livonia, Michigan.
James VandewarkerTrinity Health, Livonia, Michigan.
Scott D HalpernDepartment of Medicine, Perelman School of Medicine at the University of Pennsylvania, Philadelphia.
Yuliya LokhnyginaDuke Clinical Research Institute, Duke University School of Medicine, Durham, North Carolina.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Importance: The End-of-Life Care Index (EOLCI) was developed to predict 1-year mortality and improve communication about serious illness at the point of care. The EOLCI is widely available in US hospitals, yet external validation studies have been limited. Objective: To evaluate EOLCI model performance overall and across key patient subgroups. Design, Setting, and Participants: This prognostic study was performed from January 1, 2022, through December 31, 2023, at 39 hospitals in the Trinity Health and Kaiser Permanente Southern California (KPSC) health systems. Participants included adults (≥18 years of age) hospitalized for 36 hours or longer. Data were analyzed from September 1, 2024, through July 13, 2026. Main Outcomes and Measures: The main outcome was 1-year mortality risk as predicted by the EOLCI using a logistic regression model with inputs including age, sex, insurance, laboratory values, comorbidities, and medications. Model performance was evaluated at a risk threshold of 70% and stratified by health system, based on a use case in a large clinical trial. The evaluation used Scaled Brier Scores (SBS; range -1 to 1) for composite measures of calibration and discrimination, calibration plots, and C statistics. Patient subgroups were defined by age, sex, race and ethnicity, ethnicity alone, Medicaid status, and diagnoses. Results: Among 116 749 Trinity Health patients with 154 063 encounters (median age, 69 [IQR, 56-79] years; 79 448 [51.6%] female across all encounters), 12 054 patients (10.3%) died within 1 year. Among 94 489 KPSC patients with 133 043 encounters (median age, 70 [IQR, 57-80] years; 67 389 [50.7%] female across all encounters), 16 872 patients (17.9%) died within 1 year. The EOLCI SBS across encounters was -0.01 (95% CI, -0.03 to 0.01) at Trinity Health and 0.18 (95% CI, 0.16-0.20) at KPSC, consistent with plots indicating poor calibration in both cohorts. Model discrimination, measured by the C statistic, was 0.76 (95% CI, 0.76-0.77) at Trinity Health and 0.81 (95% CI, 0.81-0.81) at KPSC. Model performance was similar across most subgroups, but worse in the oldest subgroup and some diagnostic subgroups, depending on the health system. Conclusions and Relevance: In this prognostic study of hospitalized adults in 2 large US health systems, the EOLCI showed moderate to high discrimination but poor calibration, with reasonably equitable performance across many sociodemographic characteristics and diagnoses. These findings may inform potential opportunities and limitations for using the EOLCI in clinical settings and serve as benchmarks for health systems developing local mortality risk models.

Indexed as

MortalityTerminal CareAgedAged, 80 and overCaliforniaFemaleHumansMaleMiddle AgedPrognosisRisk AssessmentUnited States

Identifiers

PMID42726481
PMCPMC13570369

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.